MeVis Medical Solutions AG (XETRA:M3V) — Market Cap & Net Worth
Market Cap & Net Worth: MeVis Medical Solutions AG (M3V)
MeVis Medical Solutions AG (XETRA:M3V) has a market capitalization of $42.95 Million (€36.74 Million) as of August 4, 2026. Listed on the XETRA stock exchange, this Germany-based company holds position #22422 globally and #1981 in its home market, demonstrating a -2.48% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying MeVis Medical Solutions AG's stock price €23.60 by its total outstanding shares 1820000 (1.82 Million). See how much does MeVis Medical Solutions AG reinvest in capital to understand how much of operating cash flow is reinvested back into capital assets.
MeVis Medical Solutions AG Market Cap History: 2015 to 2026
MeVis Medical Solutions AG's market capitalization history from 2015 to 2026. Data shows growth from $40.55 Million to $50.22 Million (2.43% CAGR).
MeVis Medical Solutions AG Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how MeVis Medical Solutions AG's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
3.26x
MeVis Medical Solutions AG's market cap is 3.26 times its annual revenue
Latest Price to Earnings (P/E) Ratio
16.53x
MeVis Medical Solutions AG's market cap is 16.53 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $66.24 Million | $16.12 Million | $4.57 Million | 4.11x | 14.50x |
| 2017 | $70.37 Million | $18.54 Million | $5.62 Million | 3.80x | 12.52x |
| 2018 | $58.35 Million | $16.76 Million | $7.17 Million | 3.48x | 8.14x |
| 2019 | $56.77 Million | $18.07 Million | $8.07 Million | 3.14x | 7.03x |
| 2020 | $60.97 Million | $17.13 Million | $5.70 Million | 3.56x | 10.69x |
| 2021 | $62.42 Million | $16.21 Million | $4.55 Million | 3.85x | 13.73x |
| 2022 | $72.46 Million | $18.76 Million | $7.79 Million | 3.86x | 9.30x |
| 2023 | $51.58 Million | $17.34 Million | $4.92 Million | 2.97x | 10.49x |
| 2024 | $53.62 Million | $16.97 Million | $4.56 Million | 3.16x | 11.76x |
| 2025 | $52.34 Million | $16.06 Million | $3.17 Million | 3.26x | 16.53x |
Competitor Companies of M3V by Market Capitalization
Companies near MeVis Medical Solutions AG in the global market cap rankings as of August 4, 2026.
Key companies related to MeVis Medical Solutions AG by market ranking:
- Veeva Systems Inc Class A (NYSE:VEEV): Ranked #982 globally with a market cap of $27.24 Billion USD.
- Pro Medicus Ltd (AU:PME): Ranked #1913 globally with a market cap of $12.17 Billion USD ( AU$17.21 Billion AUD).
- BrightSpring Health Services, Inc. Common Stock (NASDAQ:BTSG): Ranked #2124 globally with a market cap of $10.63 Billion USD.
- Tempus AI, Inc. Class A Common Stock (NASDAQ:TEM): Ranked #2588 globally with a market cap of $8.00 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #982 | Veeva Systems Inc Class A | NYSE:VEEV | $27.24 Billion | $206.25 |
| #1913 | Pro Medicus Ltd | AU:PME | $12.17 Billion | AU$164.69 |
| #2124 | BrightSpring Health Services, Inc. Common Stock | NASDAQ:BTSG | $10.63 Billion | $60.47 |
| #2588 | Tempus AI, Inc. Class A Common Stock | NASDAQ:TEM | $8.00 Billion | $46.05 |
MeVis Medical Solutions AG Historical Marketcap From 2015 to 2026
Between 2015 and today, MeVis Medical Solutions AG's market cap moved from $40.55 Million to $ 50.22 Million, with a yearly change of 2.43%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €50.22 Million | -4.07% |
| 2025 | €52.34 Million | -2.38% |
| 2024 | €53.62 Million | +3.95% |
| 2023 | €51.58 Million | -28.81% |
| 2022 | €72.46 Million | +16.08% |
| 2021 | €62.42 Million | +2.39% |
| 2020 | €60.97 Million | +7.39% |
| 2019 | €56.77 Million | -2.70% |
| 2018 | €58.35 Million | -17.09% |
| 2017 | €70.37 Million | +6.25% |
| 2016 | €66.24 Million | +63.35% |
| 2015 | €40.55 Million | -- |
End of Day Market Cap According to Different Sources
On Aug 4th, 2026 the market cap of MeVis Medical Solutions AG was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $42.95 Million USD |
| MoneyControl | $42.95 Million USD |
| MarketWatch | $42.95 Million USD |
| marketcap.company | $42.95 Million USD |
| Reuters | $42.95 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About MeVis Medical Solutions AG
MeVis Medical Solutions AG develops software for recording, analyzing, and evaluating image data to manufacturers of medical devices, providers of medical IT platforms, and clinical end customers in the United States and Europe. The company provides image-based early detection and diagnosis of epidemiologically important diseases, such as breast, lung, liver, and neurological diseases. It also of… Read more